Colyer Sean, Avery Ellen G, Kroch Abigail E, Liu Juan, Zygmunt Austin, Kesler Maya A, Sullivan Ashleigh, Tran Vanessa
Public Health Agency of Canada, Ottawa, Ontario, Canada.
Public Health Ontario, Toronto, Ontario, Canada.
BMJ Open. 2025 Sep 9;15(9):e097142. doi: 10.1136/bmjopen-2024-097142.
Canadian guidelines recommend HIV testing for individuals being evaluated for syphilis. Our objective was to examine three aspects of HIV testing (ie, if an HIV test occurred, the timing of the HIV test in relation to the syphilis test and the proportion with a positive HIV test result) among syphilis tests between 2017 and 2022 from individuals with no evidence of a previous HIV diagnosis.
This study is a retrospective analysis of comprehensive laboratory testing data from Ontario's provincial public health laboratory.
Direct fluorescent antibody (DFA) and serological non-prenatal syphilis tests were conducted from 1 January 2017 to 31 December 2022, from individuals aged ≥15 years with no evidence of a previous HIV diagnosis (n=3 001 058 total tests). Positive syphilis tests were categorised using the rapid plasma reagin (RPR) titre as 'current' (DFA+/RPR≥1:8) or 'historical' (RPR<1:8). Exposure categories were assigned using individually linked HIV exposure category data retrieved from the laboratory's HIV DataMart.
The number and proportion of syphilis tests with a corresponding HIV test on the same day or within 7, 28, 90 or 180 days, and, among those with an HIV test within 28 days, the number and proportion with an HIV-positive test result.
From 2017 to 2022, 1 516 726 and 1 484 332 syphilis tests among males and females, respectively, were included in the analysis. Individuals with a positive syphilis result were less likely to be tested for HIV within 28 days of their syphilis test compared with those with a negative syphilis test result (74.7% vs 91.1% in males, 97.5% CI (-0.17 to -0.16); 65.2% vs 92.4% in females, 97.5% CI (-0.28 to -0.26)). Males with 'current' positive syphilis test results were less likely than males with 'historical' positive syphilis results to be tested for HIV within 28 days (69.1% vs 76.6%, 97.5% CI (-0.084 to -0.066)); this was not true in females (67.1% vs 64.4%, 97.5% CI (0.0062 to 0.049)). Males overall and males with 'current' syphilis were more likely to be diagnosed as HIV-positive (p<0.025).
Most individuals who tested for syphilis at Public Health Ontario were also tested for HIV; however, those who tested positive for syphilis were less likely to be tested, representing an opportunity for enhanced HIV testing. Ensuring that individuals with syphilis are tested for HIV may help identify previously undiagnosed individuals living with HIV.
加拿大指南建议对接受梅毒评估的个体进行HIV检测。我们的目的是研究2017年至2022年期间,在无既往HIV诊断证据的个体的梅毒检测中,HIV检测的三个方面(即是否进行了HIV检测、HIV检测相对于梅毒检测的时间以及HIV检测结果为阳性的比例)。
本研究是对安大略省省级公共卫生实验室的综合实验室检测数据进行的回顾性分析。
2017年1月1日至2022年12月31日期间,对年龄≥15岁、无既往HIV诊断证据的个体进行了直接荧光抗体(DFA)和血清学非产前梅毒检测(共3 001 058次检测)。梅毒检测呈阳性者根据快速血浆反应素(RPR)滴度分为“现症”(DFA+/RPR≥1:8)或“既往”(RPR<1:8)。暴露类别使用从实验室的HIV数据仓库中检索到的个体关联HIV暴露类别数据进行分配。
同一天或7、28、90或180天内进行相应HIV检测的梅毒检测的数量和比例,以及在28天内进行HIV检测的个体中,HIV检测结果为阳性的数量和比例。
2017年至2022年期间,分析纳入了男性1 516 726次和女性1 484 332次梅毒检测。与梅毒检测结果为阴性的个体相比,梅毒检测结果为阳性的个体在梅毒检测后28天内接受HIV检测的可能性较小(男性为74.7%对91.1%,97.5%CI(-0.17至-0.16);女性为65.2%对92.4%,97.5%CI(-0.28至-0.26))。“现症”梅毒检测结果为阳性的男性在28天内接受HIV检测的可能性低于“既往”梅毒检测结果为阳性的男性(69.1%对76.6%,97.5%CI(-0.084至-0.066));女性情况并非如此(67.1%对64.4%,97.5%CI(0.0062至0.049))。总体男性以及“现症”梅毒男性更有可能被诊断为HIV阳性(p<0.025)。
在安大略省公共卫生部门接受梅毒检测的大多数个体也接受了HIV检测;然而,梅毒检测呈阳性的个体接受检测的可能性较小,这是加强HIV检测的一个机会。确保对梅毒患者进行HIV检测可能有助于识别先前未被诊断的HIV感染者。